An interventional study of High intensity gait training in a balance challenging Movement amplification environment in Stroke, sponsored by Northwestern University. Completed at 1 site in United States. Open to participants aged 18 Years to 85 Years. Per ClinicalTrials.gov, last updated 2026-11-18.
Sponsored by Northwestern University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 24 studies in Stroke by Northwestern University — 6 open to participants now, 8 under way, none of them phase 3. Stroke · Northwestern University.
Among the 24 studies in Stroke by Northwestern University, this one is the 15th largest by enrollment of the 20 interventional ones that give a count, is one of 2 that started in 2023, is one of 17 with no phase, and was the 20th registered.
8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.
Browse Stroke studies →6 of the 24 studies in Stroke by Northwestern University are open now, in 1 country. Recruiting first, the newest first:
Northwestern University · Sites in United States
Ages 18–85
Northwestern University · Sites in United States
Ages 18–80 · Healthy volunteers
Northwestern University · Sites in United States
Ages 18+ · Healthy volunteers
Northwestern University · Sites in United States
Ages 21–100
Northwestern University · Sites in United States
Ages 21+
By country, each count listing its studies:
Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.
This study: 18 Years to 85 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
24 studies; the count open now beside each. This study's row is marked.
First in 2005; this study’s year is marked. 2 started in 2023.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 33 is below the median of 48 across 6,049 interventional studies indexed under Stroke.
Median enrollment 52 across the 20 interventional studies, 104 across the 4 observational. Of the 15 that completed or were terminated, 6 (40%) have results posted.
This tab as a report to print or save as PDF → With an account.
Northwestern University is the lead sponsor of 1,424 studies on the registry; 199 are open to participants now.
Of its 105 completed or terminated interventional studies of FDA-regulated products, 78 (74%) have results posted.
2 of the studies in Stroke by Northwestern University that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT04312269Northwestern UniversityCombining MyoCI With Memory Reactivation to Improve Motor Recovery After Stroke | 2027-01-30 |
| NCT03401762Northwestern UniversityWearable MCI to Reduce Muscle Co-activation in Acute and Chronic Stroke | 2027-04 |
Add all 2 to your calendar (.ics) → With an account.
Among the 24 studies in Stroke by Northwestern University, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Stroke is one of the leading causes of disability in the United States, affecting \~795,000 people annually. Among ambulatory people with chronic stroke, impaired balance is common and substantially limits mobility (those with the poorest balance walk the least). This project will explore if a novel gait training intervention using a robotic device to amplify a person's self-generated movements can improve walking balance in people with chronic stroke. The development of effective interventions to increase walking balance among people with chronic stroke will positively impact quality of life and ability to participate in walking activities.
Background: People with chronic stroke (PwCS) have substantial walking balance dysfunctions that limit independence and participation in walking activities. There is a pressing need to develop effective methods to enhance walking balance in PwCS. Interventions that amplify self-generated movements may accelerate motor learning by enhance a person's perception of movement errors. This method could potentially be applied to help PwCS improve walking balance. To this end, we have developed a cable-driven robot to create a Movement Amplification Environment (MAE) during treadmill walking. The MAE challenges walking balance by applying lateral forces to the pelvis that are proportional in magnitude to real-time lateral center of mass (COM) velocity. Our purpose is to evaluate effects of MAE training on walking balance in PwCS.
Specific Aims: Aim 1a: To quantify locomotor adaptations PwCS make to maintain walking balance in a MAE. We will evaluate the impact of the two foremost gait training variables: Gait Speed and MAE Strength. Aim 1b: To evaluate short-term changes in the ability of PwCS to control their lateral COM excursion during walking (a quantifiable walking balance measure) immediately after MAE training. Aim 2: To evaluate long-term changes in walking balance and daily walking following a 5-week high-intensity gait training intervention performed in a MAE.
Approach: Aims 1a \& b: Twenty PwCS will each participate in two experiments evaluating gait biomechanics (COM dynamics and stepping patterns) during and immediately following MAE training. Aim 1a will evaluate locomotor adaptations when walking in a MAE and the effect of gait speed (slow, preferred, and fast) and MAE strength (low, medium, and high). Aim 1b will use visual feedback to challenge PwCS to control their lateral COM excursion during walking immediately before and after walking in different external conditions (No applied forces, or MAE). Outcomes will assess if short-term walking balance is enhanced immediately following MAE exposure. Aim 2: Ten PwCS will participate in 10-sessions of high intensity gait training performed in a MAE. We will assess pre- to post- changes in walking balance using clinical gait and balance measures, biomechanical assessments, and participation in daily walking (steps/day). Outcomes will assess if long-term walking balance is enhanced following MAE gait training.
Impact: Training walking balance of PwCS by amplifying their own self-generated movements is a radical departure from current practice and could substantially enhance walking balance. This study will provide a foundational understanding of how PwCS maintain walking balance in a MAE and if beneficial behaviors persist following MAE training. Successful outcomes will motivate a randomized controlled trial assessing efficacy of MAE training on walking balance in PwCS.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
MMSE and MoCA
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
For Aim 1a, participant's preferred and fast treadmill walking speeds will be determined followed by 2-min of baseline walking. Each participant will perform eight 2-min trials of treadmill walking 1) Null Environment: no forces, 2) MAE Low Gain: 25 Nsm-1, 3) MAE Medium Gain: 35 Nsm-1, 4) MAE High Gain: 45 Nsm-1, that will be repeated at both treadmill walking speeds. The trial order will be randomized. For Aim 1b, we will assess participant's maximum ability to control their lateral COM motion with no forces applied, using three 21-meter walking trials with visual projections on the treadmill to provide feedback used to challenge their lateral COM motion control. Five 2-min trials in a Null environment will be followed by COM control assessment. Participants will rest and repeat the above sequence in a MAE. The order of the external environments will be randomized across participants. Participants may participate in more than one aim (1a, 1b and 2).
Other: High intensity gait training in a balance challenging Movement amplification environment
For Aim 2, each participant will engage in ten 45-min high-intensity gait training sessions performed in a Movement Amplification Environment (MAE). Training sessions will occur 2x/week and led by a licensed Physical Therapist. The goal of each training session is to achieve 40-min of stepping practice within a targeted range of heart rate (HR) of 70 to 80% of estimated age-predicted HR max and perceived excursion (RPE) in a MAE. Each session will begin and end with a 2.5-min warm-up and cool down, with 40-min of training using two 10-min Speed-training blocks and two 10-min Balance-training blocks. Balance training activities will include lateral maneuvers, head turns, obstacle negotiation, and backward walking. The MAE gain, training speeds and balance activities will be progressively increased within and across sessions to challenge the participant.
Gait Stability (Short-term Lyapunov Exponent)
Gait stability was measured using the short-term Lyapunov exponent that quantifies the average logarithmic rate of divergence of a system after small kinematic deviations. This metric has demonstrated construct and predictive validity in prior simulation and walking studies where divergence is respective to the gait cycle. The lateral COM velocity (VCOM) was used for this calculation as a measure of local, dynamic stability. Lower values of the short-term Lyapunov exponent indicates higher stability and higher values indicates lower stability and greater challenge to walking balance. For Aim 1a, gait stability was calculated at session 1 (baseline). For Aim 1b, gait stability was calculated at session 2 and 3. For Aim 2, gait stability was calculated at session 4 (pre-training) and session 15 (post-training).
Time frame: Session 1 was baseline; Sessions 2 and 3 occurred one week apart within 2 weeks to 10 months of baseline. Pre-training assessment (Session 4) occurred one year after baseline, and post-training assessment (Session 15) followed five weeks later.
Lateral Center of Mass (COM) Excursion
Lateral center of mass (COM) excursion occurring during 5 consecutive gait cycles was calculated as our metric of ability to control lateral COM motion during walking. Kinematic marker data was processed using Visual3D (C-Motion, Germantown, MD) and a custom MATLAB (Mathworks, Natick, MA) program. Marker data was gap-filled and low-pass filtered (Butterworth, 6 Hz cut-off frequency). Time of initial foot contact (IC) and toe-off (TO) events were identified for each step based on fore-aft positions of the calcaneus and 2nd metatarsal markers. A reduction in the mean lateral COM excursion suggests improved walking balance or adaptive response towards changing gains. For Aim 1a, COM excursion was calculated at session 1. For Aim 1b, gait stability was calculated at session 2 and 3. For Aim 2, COM excursion was calculated at session 4 (pre-training) and session 15 (post-training).
Time frame: Session 1 was baseline; Sessions 2 and 3 occurred one week apart within 2 weeks to 10 months of baseline. Pre-training assessment (Session 4) occurred one year after baseline, and post-training assessment (Session 15) followed five weeks later.
Lateral Center of Mass (COM) Velocity
Lateral center of mass (COM) velocity was calculated by taking the derivative of filtered COM position (same filter as marker data). The average of absolute value of lateral COM velocity peaks in both directions were calculated. For Aim 1a, COM velocity was calculated at session 1. For Aim 1b, velocity was calculated at session 2 and 3. For Aim 2, COM velocity was calculated at session 4 (pre-training) and session 15 (post-training).
Time frame: Session 1 was baseline; Sessions 2 and 3 occurred one week apart within 2 weeks to 10 months of baseline. Pre-training assessment (Session 4) occurred one year after baseline, and post-training assessment (Session 15) followed five weeks later.
Ten Minute Walk Test (10MWT) at Preferred Speed
Ten minute walk test (10MWT) is a simple measurement of an individual's average walking speed measured at self-selected speed (instruction: "walk at your normal comfortable pace"). For Aim 2, 10MWT was collected at session 4 (pre-training) and session 15 (post-training).
Time frame: Pre-training assessment (Session 4) occurred one year after baseline, and post-training assessment (Session 15) followed five weeks later.
Ten Minute Walk Test (10MWT) at Fast Speed
Ten minute walk test (10MWT) is a simple measurement of an individual's average walking speed measured at fast speed (instruction: "walk as fast as you can safely walk"). For Aim 2, 10MWT was collected at session 4 (pre-training) and session 15 (post-training).
Time frame: Pre-training assessment (Session 4) occurred one year after baseline, and post-training assessment (Session 15) followed five weeks later.
Dynamic Gait Index (DGI)
DGI is a clinical assessment tool used to evaluate an individual's balance, walking ability, and fall risk. It tests how well a person can adapt their gait to external demands, such as navigating obstacles and turning their head, rather than just walking on a flat surface. Each task is graded on a 4-point ordinal scale (0 to 3), where 3 indicates normal function with no impairments, and 0 indicates severe impairment (e.g., losing balance or requiring physical assistance). The total score of DGI is 24, with a minimum score of 0 and maximum score of 24. Higher scores indicate better balance, while lower scores indicate poor balance. For Aim 2, DGI was calculated at session 4 (pre-training) and session 15 (post-training).
Time frame: Pre-training assessment (Session 4) occurred one year after baseline, and post-training assessment (Session 15) followed five weeks later.
Berg Balance Scale (BBS)
BBS is a 14-item measure that assesses static balance with excellent validity and reliability in individuals post-stroke. The total score for this test is 56. Minimum score is 0 and maximum score is 56. Higher scores indicate better balance and lower fall-risk, while lower scores indicate poor balance and increased fall-risk. For Aim 2, BBS was calculated at session 4 (pre-training) and session 15 (post-training).
Time frame: Pre-training assessment (Session 4) occurred one year after baseline, and post-training assessment (Session 15) followed five weeks later.
Timed up and go Test (TUG)
TUG was used to assess functional mobility, walking balance, and fall risk. It is a quick, valid, reliable and widely used clinical performance based measure in individuals post-stroke. While there is no time limit to the TUG test, more time taken to finish the task indicates poor balance and greater fall-risk. For Aim 2, TUG was calculated at session 4 (pre-training) and session 15 (post-training).
Time frame: Pre-training assessment (Session 4) occurred one year after baseline, and post-training assessment (Session 15) followed five weeks later.
Activities-specific Balance Confidence (ABC) Scale
ABC scale is a self-reported measure of an individual's confidence while performing specific postural and ambulatory activities. The ABC is a reliable and valid measure of balance confidence in individuals post-stroke. The total score for ABC scale is 100. Minimum score is 0 and maximum score is 100. Higher scores indicate better balance confidence, while lower scores indicate poor balance confidence. For Aim 2, ABC scale was calculated at session 4 (pre-training) and session 15 (post-training).
Time frame: Pre-training assessment (Session 4) occurred one year after baseline, and post-training assessment (Session 15) followed five weeks later.
Six Minute Walk Distance (6MWD)
Six minute walk test is a sub-maximal exercise test used to assess aerobic capacity and endurance. The distance covered during 6 minutes of walking indicate participants exercise tolerance. The vitals measures before and after the 6MWT indicate the cardiovascular and respiratory response to exercise. For Aim 2, 6MWD was collected at session 4 (pre-training) and session 15 (post-training).
Time frame: Pre-training assessment (Session 4) occurred one year after baseline, and post-training assessment (Session 15) followed five weeks later.
Daily Stepping in the Home and Community
The amount of daily stepping in the home and community taken per day averaged across the 7-day collection periods was collected before and after 10 high intensity gait training session in MAE in Aim 2. Daily stepping was measured and recorded using a StepWatch4 (Modus, Edmonds, WA) activity monitor. The microprocessor-based accelerometer was worn around the ankle during all waking hours (except bathing) for the duration of the stepping assessment period. For Aim 2, daily stepping was calculated at session 4 (pre-training) and session 15 (post-training).
Time frame: Pre-training assessment (Session 4) occurred one year after baseline, and post-training assessment (Session 15) followed five weeks later.
Step Width
Step width was calculated as the medio-lateral distance between the left and right 5th Metatarsal markers at initial foot contact. For Aim 1a, step width was calculated at session 1. For Aim 1b, step width was calculated at session 2 and 3.
Time frame: Session 1 was baseline; Sessions 2 and 3 occurred one week apart within 2 weeks to 10 months of baseline. Pre-training assessment (Session 4) occurred one year after baseline, and post-training assessment (Session 15) followed five weeks later.
Step Length
Step length was calculated as the anteroposterior distance between the calcaneal markers of the leading and trailing limbs at heel strike for each stride. For Aim 1a, step length was calculated at session 1. For Aim 1b, step length was calculated at session 2 and 3.
Time frame: Session 1 was baseline; Sessions 2 and 3 occurred one week apart within 2 weeks to 10 months of baseline. Pre-training assessment (Session 4) occurred one year after baseline, and post-training assessment (Session 15) followed five weeks later.
33 participants had consented for this study for participation. Out of which, 3 participants were excluded and 1 participant dropped out.
| Milestone | Aim 1 | Aim 2 |
|---|---|---|
| Started | 22 | 11 |
| Completed | 19 | 10 |
| Not completed | 3 | 1 |
| Withdrew: Lost to follow-up | 0 | 1 |
| Withdrew: Excluded from the study | 3 | 0 |
Gait stability was measured using the short-term Lyapunov exponent that quantifies the average logarithmic rate of divergence of a system after small kinematic deviations. This metric has demonstrated construct and predictive validity in prior simulation and walking studies where divergence is respective to the gait cycle. The lateral COM velocity (VCOM) was used for this calculation as a measure of local, dynamic stability. Lower values of the short-term Lyapunov exponent indicates higher stability and higher values indicates lower stability and greater challenge to walking balance. For Aim 1a, gait stability was calculated at session 1 (baseline). For Aim 1b, gait stability was calculated at session 2 and 3. For Aim 2, gait stability was calculated at session 4 (pre-training) and session 15 (post-training).
| second-¹ (s-¹) | Aim 1a_Preferred speed_Null | Aim 1a_Preferred speed_Low MAE | Aim 1a_Preferred speed_Medium MAE | Aim 1a_Preferred speed_High MAE | Aim 1a_Fast speed_Null | Aim 1a_Fast speed_Low MAE | Aim 1a_Fast speed_Medium MAE | Aim 1a_Fast speed_High MAE | Aim 1b_Early_MAE | Aim 1b_Late_MAE | Aim 1b_Early_Null | Aim 1b_Late_Null | Aim 2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Session 1 | 2.09 ± 0.34 | 2.33 ± 0.37 | 2.34 ± 0.30 | 2.33 ± 0.41 | 2.11 ± 0.27 | 2.31 ± 0.44 | 2.35 ± 0.33 | 2.31 ± 0.37 | — | — | — | — | — |
| Session 2 | — | — | — | — | — | — | — | — | 2.44 ± 0.35 | 2.45 ± 0.39 | — | — | — |
| Session 3 | — | — | — | — | — | — | — | — | — | — | 2.17 ± 0.27 | 2.16 ± 0.28 | — |
| Session 4 (Pre-training) | — | — | — | — | — | — | — | — | — | — | — | — | 2.24 ± 0.24 |
| Session 15 (Post-training) | — | — | — | — | — | — | — | — | — | — | — | — | 2.12 ± 0.23 |
Lateral center of mass (COM) excursion occurring during 5 consecutive gait cycles was calculated as our metric of ability to control lateral COM motion during walking. Kinematic marker data was processed using Visual3D (C-Motion, Germantown, MD) and a custom MATLAB (Mathworks, Natick, MA) program. Marker data was gap-filled and low-pass filtered (Butterworth, 6 Hz cut-off frequency). Time of initial foot contact (IC) and toe-off (TO) events were identified for each step based on fore-aft positions of the calcaneus and 2nd metatarsal markers. A reduction in the mean lateral COM excursion suggests improved walking balance or adaptive response towards changing gains. For Aim 1a, COM excursion was calculated at session 1. For Aim 1b, gait stability was calculated at session 2 and 3. For Aim 2, COM excursion was calculated at session 4 (pre-training) and session 15 (post-training).
| cms | Aim 1a_Preferred speed_Null | Aim 1a_Preferred speed_Low MAE | Aim 1a_Preferred speed_Medium MAE | Aim 1a_Preferred speed_High MAE | Aim 1a_Fast speed_Null | Aim 1a_Fast speed_Low MAE | Aim 1a_Fast speed_Medium MAE | Aim 1a_Fast speed_High MAE | Aim 1b_Early_MAE | Aim 1b_Late_MAE | Aim 1b_Early_Null | Aim 1b_Late_Null | Aim 2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Session 1 | 0.112 ± 0.029 | 0.102 ± 0.027 | 0.107 ± 0.027 | 0.111 ± 0.028 | 0.100 ± 0.025 | 0.094 ± 0.026 | 0.097 ± 0.026 | 0.097 ± 0.026 | — | — | — | — | — |
| Session 2 | — | — | — | — | — | — | — | — | 0.095 ± 0.025 | 0.097 ± 0.027 | — | — | — |
| Session 3 | — | — | — | — | — | — | — | — | — | — | 0.102 ± 0.024 | 0.106 ± 0.026 | — |
| Session 4 (Pre-training) | — | — | — | — | — | — | — | — | — | — | — | — | 0.106 ± 0.028 |
| Session 15 (Post-training) | — | — | — | — | — | — | — | — | — | — | — | — | 0.098 ± 0.030 |
Lateral center of mass (COM) velocity was calculated by taking the derivative of filtered COM position (same filter as marker data). The average of absolute value of lateral COM velocity peaks in both directions were calculated. For Aim 1a, COM velocity was calculated at session 1. For Aim 1b, velocity was calculated at session 2 and 3. For Aim 2, COM velocity was calculated at session 4 (pre-training) and session 15 (post-training).
| cms/second | Aim 1a_Preferred speed_Null | Aim 1a_Preferred speed_Low MAE | Aim 1a_Preferred speed_Medium MAE | Aim 1a_Preferred speed_High MAE | Aim 1a_Fast speed_Null | Aim 1a_Fast speed_Low MAE | Aim 1a_Fast speed_Medium MAE | Aim 1a_Fast speed_High MAE | Aim 1b_Early_MAE | Aim 1b_Late_MAE | Aim 1b_Early_Null | Aim 1b_Late_Null | Aim 2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Session 1 | 0.0031 ± 0.0008 | 0.0030 ± 0.0009 | 0.0030 ± 0.0008 | 0.0032 ± 0.0009 | 0.0044 ± 0.0040 | 0.0033 ± 0.0008 | 0.0034 ± 0.0008 | 0.0034 ± 0.0008 | — | — | — | — | — |
| Session 2 | — | — | — | — | — | — | — | — | 0.0032 ± 0.0008 | 0.0031 ± 0.0007 | — | — | — |
| Session 3 | — | — | — | — | — | — | — | — | — | — | 0.0032 ± 0.0008 | 0.0032 ± 0.0009 | — |
| Session 4 (Pre-training) | — | — | — | — | — | — | — | — | — | — | — | — | 0.0030 ± 0.0006 |
| Session 15 (Post-training) | — | — | — | — | — | — | — | — | — | — | — | — | 0.0032 ± 0.0004 |
BBS is a 14-item measure that assesses static balance with excellent validity and reliability in individuals post-stroke. The total score for this test is 56. Minimum score is 0 and maximum score is 56. Higher scores indicate better balance and lower fall-risk, while lower scores indicate poor balance and increased fall-risk. For Aim 2, BBS was calculated at session 4 (pre-training) and session 15 (post-training).
| units | Aim 1a_Preferred speed_Null | Aim 1a_Preferred speed_Low MAE | Aim 1a_Preferred speed_Medium MAE | Aim 1a_Preferred speed_High MAE | Aim 1a_Fast speed_Null | Aim 1a_Fast speed_Low MAE | Aim 1a_Fast speed_Medium MAE | Aim 1a_Fast speed_High MAE | Aim 1b_Early_MAE | Aim 1b_Late_MAE | Aim 1b_Early_Null | Aim 1b_Late_Null | Aim 2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Session 4 (Pre-training) | — | — | — | — | — | — | — | — | — | — | — | — | 47.50 ± 5.46 |
| Session 15 (Post-training) | — | — | — | — | — | — | — | — | — | — | — | — | 50.40 ± 3.47 |
TUG was used to assess functional mobility, walking balance, and fall risk. It is a quick, valid, reliable and widely used clinical performance based measure in individuals post-stroke. While there is no time limit to the TUG test, more time taken to finish the task indicates poor balance and greater fall-risk. For Aim 2, TUG was calculated at session 4 (pre-training) and session 15 (post-training).
| seconds | Aim 1a_Preferred speed_Null | Aim 1a_Preferred speed_Low MAE | Aim 1a_Preferred speed_Medium MAE | Aim 1a_Preferred speed_High MAE | Aim 1a_Fast speed_Null | Aim 1a_Fast speed_Low MAE | Aim 1a_Fast speed_Medium MAE | Aim 1a_Fast speed_High MAE | Aim 1b_Early_MAE | Aim 1b_Late_MAE | Aim 1b_Early_Null | Aim 1b_Late_Null | Aim 2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Session 4 (Pre-training) | — | — | — | — | — | — | — | — | — | — | — | — | 13.77 ± 2.40 |
| Session 15 (Post-training) | — | — | — | — | — | — | — | — | — | — | — | — | 13.29 ± 3.48 |
ABC scale is a self-reported measure of an individual's confidence while performing specific postural and ambulatory activities. The ABC is a reliable and valid measure of balance confidence in individuals post-stroke. The total score for ABC scale is 100. Minimum score is 0 and maximum score is 100. Higher scores indicate better balance confidence, while lower scores indicate poor balance confidence. For Aim 2, ABC scale was calculated at session 4 (pre-training) and session 15 (post-training).
| units | Aim 1a_Preferred speed_Null | Aim 1a_Preferred speed_Low MAE | Aim 1a_Preferred speed_Medium MAE | Aim 1a_Preferred speed_High MAE | Aim 1a_Fast speed_Null | Aim 1a_Fast speed_Low MAE | Aim 1a_Fast speed_Medium MAE | Aim 1a_Fast speed_High MAE | Aim 1b_Early_MAE | Aim 1b_Late_MAE | Aim 1b_Early_Null | Aim 1b_Late_Null | Aim 2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Session 4 (Pre-training) | — | — | — | — | — | — | — | — | — | — | — | — | 73.65 ± 12.65 |
| Session 15 (Post-training) | — | — | — | — | — | — | — | — | — | — | — | — | 76.65 ± 12.67 |
Six minute walk test is a sub-maximal exercise test used to assess aerobic capacity and endurance. The distance covered during 6 minutes of walking indicate participants exercise tolerance. The vitals measures before and after the 6MWT indicate the cardiovascular and respiratory response to exercise. For Aim 2, 6MWD was collected at session 4 (pre-training) and session 15 (post-training).
| meters | Aim 1a_Preferred speed_Null | Aim 1a_Preferred speed_Low MAE | Aim 1a_Preferred speed_Medium MAE | Aim 1a_Preferred speed_High MAE | Aim 1a_Fast speed_Null | Aim 1a_Fast speed_Low MAE | Aim 1a_Fast speed_Medium MAE | Aim 1a_Fast speed_High MAE | Aim 1b_Early_MAE | Aim 1b_Late_MAE | Aim 1b_Early_Null | Aim 1b_Late_Null | Aim 2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Session 4 (Pre-training) | — | — | — | — | — | — | — | — | — | — | — | — | 266.21 ± 79.75 |
| Session 15 (Post-training) | — | — | — | — | — | — | — | — | — | — | — | — | 283.26 ± 66.13 |
The amount of daily stepping in the home and community taken per day averaged across the 7-day collection periods was collected before and after 10 high intensity gait training session in MAE in Aim 2. Daily stepping was measured and recorded using a StepWatch4 (Modus, Edmonds, WA) activity monitor. The microprocessor-based accelerometer was worn around the ankle during all waking hours (except bathing) for the duration of the stepping assessment period. For Aim 2, daily stepping was calculated at session 4 (pre-training) and session 15 (post-training).
| Number of steps per day | Aim 1a_Preferred speed_Null | Aim 1a_Preferred speed_Low MAE | Aim 1a_Preferred speed_Medium MAE | Aim 1a_Preferred speed_High MAE | Aim 1a_Fast speed_Null | Aim 1a_Fast speed_Low MAE | Aim 1a_Fast speed_Medium MAE | Aim 1a_Fast speed_High MAE | Aim 1b_Early_MAE | Aim 1b_Late_MAE | Aim 1b_Early_Null | Aim 1b_Late_Null | Aim 2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Session 4 (Pre-training) | — | — | — | — | — | — | — | — | — | — | — | — | 3410.24 ± 1804.62 |
| Session 15 (Post-training) | — | — | — | — | — | — | — | — | — | — | — | — | 2934.75 ± 1617.75 |
Step width was calculated as the medio-lateral distance between the left and right 5th Metatarsal markers at initial foot contact. For Aim 1a, step width was calculated at session 1. For Aim 1b, step width was calculated at session 2 and 3.
| cms | Aim 1a_Preferred speed_Null | Aim 1a_Preferred speed_Low MAE | Aim 1a_Preferred speed_Medium MAE | Aim 1a_Preferred speed_High MAE | Aim 1a_Fast speed_Null | Aim 1a_Fast speed_Low MAE | Aim 1a_Fast speed_Medium MAE | Aim 1a_Fast speed_High MAE | Aim 1b_Early_MAE | Aim 1b_Late_MAE | Aim 1b_Early_Null | Aim 1b_Late_Null | Aim 2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Session 1 | 0.309 ± 0.051 | 0.310 ± 0.050 | 0.314 ± 0.050 | 0.318 ± 0.051 | 0.306 ± 0.056 | 0.310 ± 0.055 | 0.310 ± 0.051 | 0.311 ± 0.053 | — | — | — | — | — |
| Session 2 | — | — | — | — | — | — | — | — | 0.313 ± 0.058 | 0.313 ± 0.059 | — | — | — |
| Session 3 | — | — | — | — | — | — | — | — | — | — | 0.301 ± 0.051 | 0.303 ± 0.053 | — |
Step length was calculated as the anteroposterior distance between the calcaneal markers of the leading and trailing limbs at heel strike for each stride. For Aim 1a, step length was calculated at session 1. For Aim 1b, step length was calculated at session 2 and 3.
| cms | Aim 1a_Preferred speed_Null | Aim 1a_Preferred speed_Low MAE | Aim 1a_Preferred speed_Medium MAE | Aim 1a_Preferred speed_High MAE | Aim 1a_Fast speed_Null | Aim 1a_Fast speed_Low MAE | Aim 1a_Fast speed_Medium MAE | Aim 1a_Fast speed_High MAE | Aim 1b_Early_MAE | Aim 1b_Late_MAE | Aim 1b_Early_Null | Aim 1b_Late_Null | Aim 2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Session 1 | 0.281 ± 0.114 | 0.277 ± 0.113 | 0.276 ± 0.112 | 0.280 ± 0.109 | 0.339 ± 0.121 | 0.341 ± 0.121 | 0.343 ± 0.122 | 0.337 ± 0.118 | — | — | — | — | — |
| Session 2 | — | — | — | — | — | — | — | — | 0.306 ± 0.124 | 0.311 ± 0.126 | — | — | — |
| Session 3 | — | — | — | — | — | — | — | — | — | — | 0.316 ± 0.126 | 0.318 ± 0.126 | — |
Ten minute walk test (10MWT) is a simple measurement of an individual's average walking speed measured at self-selected speed (instruction: "walk at your normal comfortable pace"). For Aim 2, 10MWT was collected at session 4 (pre-training) and session 15 (post-training).
| meters/second | Aim 1a_Preferred speed_Null | Aim 1a_Preferred speed_Low MAE | Aim 1a_Preferred speed_Medium MAE | Aim 1a_Preferred speed_High MAE | Aim 1a_Fast speed_Null | Aim 1a_Fast speed_Low MAE | Aim 1a_Fast speed_Medium MAE | Aim 1a_Fast speed_High MAE | Aim 1b_Early_MAE | Aim 1b_Late_MAE | Aim 1b_Early_Null | Aim 1b_Late_Null | Aim 2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Session 4 (Pre-training) | — | — | — | — | — | — | — | — | — | — | — | — | 0.851 ± 0.242 |
| Session 15 (Post-training) | — | — | — | — | — | — | — | — | — | — | — | — | 0.854 ± 0.199 |
Ten minute walk test (10MWT) is a simple measurement of an individual's average walking speed measured at fast speed (instruction: "walk as fast as you can safely walk"). For Aim 2, 10MWT was collected at session 4 (pre-training) and session 15 (post-training).
| meters/second | Aim 1a_Preferred speed_Null | Aim 1a_Preferred speed_Low MAE | Aim 1a_Preferred speed_Medium MAE | Aim 1a_Preferred speed_High MAE | Aim 1a_Fast speed_Null | Aim 1a_Fast speed_Low MAE | Aim 1a_Fast speed_Medium MAE | Aim 1a_Fast speed_High MAE | Aim 1b_Early_MAE | Aim 1b_Late_MAE | Aim 1b_Early_Null | Aim 1b_Late_Null | Aim 2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Session 4 (Pre-training) | — | — | — | — | — | — | — | — | — | — | — | — | 1.175 ± 0.386 |
| Session 15 (Post-training) | — | — | — | — | — | — | — | — | — | — | — | — | 1.143 ± 0.337 |
DGI is a clinical assessment tool used to evaluate an individual's balance, walking ability, and fall risk. It tests how well a person can adapt their gait to external demands, such as navigating obstacles and turning their head, rather than just walking on a flat surface. Each task is graded on a 4-point ordinal scale (0 to 3), where 3 indicates normal function with no impairments, and 0 indicates severe impairment (e.g., losing balance or requiring physical assistance). The total score of DGI is 24, with a minimum score of 0 and maximum score of 24. Higher scores indicate better balance, while lower scores indicate poor balance. For Aim 2, DGI was calculated at session 4 (pre-training) and session 15 (post-training).
| units | Aim 1a_Preferred speed_Null | Aim 1a_Preferred speed_Low MAE | Aim 1a_Preferred speed_Medium MAE | Aim 1a_Preferred speed_High MAE | Aim 1a_Fast speed_Null | Aim 1a_Fast speed_Low MAE | Aim 1a_Fast speed_Medium MAE | Aim 1a_Fast speed_High MAE | Aim 1b_Early_MAE | Aim 1b_Late_MAE | Aim 1b_Early_Null | Aim 1b_Late_Null | Aim 2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Session 4 (Pre-training) | — | — | — | — | — | — | — | — | — | — | — | — | 14.30 ± 2.15 |
| Session 15 (Post-training) | — | — | — | — | — | — | — | — | — | — | — | — | 15.00 ± 1.41 |
Collected over Adverse event data were monitored for each participant for 3 weeks in Aim 1 and for 7 weeks in Aim 2.. Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Aim 1 | 0/19 (0%) | 0/19 (0%) | 0/19 (0%) |
| Aim 2 | 0/10 (0%) | 0/10 (0%) | 0/10 (0%) |
| Age, Continuous(Years) | Aim 1 | Aim 2 | Total |
|---|---|---|---|
| Mean | 62.84 ± 8.47 | 63.30 ± 6.67 | 63.00 ± 7.81 |
| Sex: Female, Male(Participants) | Aim 1 | Aim 2 | Total |
|---|---|---|---|
| Female | 5 | 3 | 8 |
| Male | 14 | 7 | 21 |
| Race (NIH/OMB)(Participants) | Aim 1 | Aim 2 | Total |
|---|---|---|---|
| American Indian or Alaska Native | 0 | 0 | 0 |
| Asian | 2 | 3 | 5 |
| Native Hawaiian or Other Pacific Islander | 0 | 0 | 0 |
| Black or African American | 10 | 2 | 12 |
| White | 7 | 5 | 12 |
| More than one race | 0 | 0 | 0 |
| Unknown or Not Reported | 0 | 0 | 0 |
| Ethnicity (NIH/OMB)(Participants) | Aim 1 | Aim 2 | Total |
|---|---|---|---|
| Hispanic or Latino | 1 | 0 | 1 |
| Not Hispanic or Latino | 17 | 10 | 27 |
| Unknown or Not Reported | 1 | 0 | 1 |
| 10 Meter Walk Test (10MWT) at preferred walking speed(Meters per second) | Aim 1 | Aim 2 | Total |
|---|---|---|---|
| Mean | 0.82 ± 0.19 | 0.85 ± 0.25 | 0.83 ± 0.21 |
| Timed Up and Go (TUG)(Seconds) | Aim 1 | Aim 2 | Total |
|---|---|---|---|
| Mean | 13.87 ± 4.59 | 13.77 ± 2.4 | 13.84 ± 3.98 |
| Dynamic Gait Index (DGI)(units on a scale) | Aim 1 | Aim 2 | Total |
|---|---|---|---|
| Mean | 15.89 ± 2.85 | 14.3 ± 2.15 | 15.34 ± 2.73 |
| Berg Balance Scale (BBS)(units on a scale) | Aim 1 | Aim 2 | Total |
|---|---|---|---|
| Mean | 48.16 ± 4.21 | 47.50 ± 5.46 | 47.93 ± 4.69 |
3 further baseline measures are reported on the registry.
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: Yes — De-identified data from this study will be uploaded on the Northwestern University Research and Data repository (Arch) so that it is fully available to other parties interested in probing the data further and performing secondary analyses.
Supporting information: Study protocol
Time frame: After completion of the study
Access criteria: Data will be publicly available.
Ran from Aug 2023 to primary completion in May 2025, 20 months.
Results were first posted in Nov 2026, 1 year 6 months after primary completion.
Of 3,121 non-industry interventional studies with no phase under Stroke, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 46. This study's 20 months is below that.
Counting every sponsor, half of 3,265 studies reached it within 23 months; a quarter within 10 and three quarters within 46.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.